Kalaris Therapeutics Inc Share Price Today: Live Updates & Key Insights
Kalaris Therapeutics Inc share price today is $6.56, up -3.52%. The stock opened at $6.755 against the previous close of $6.81, with an intraday high of $6.755 and low of $6.56.
Kalaris Therapeutics Inc Share Price Chart
Kalaris Therapeutics Inc
Kalaris Therapeutics Inc Share Price Performance
Kalaris Therapeutics Inc Institutional Holdings
Kalaris Therapeutics Inc Market Status
Kalaris Therapeutics Inc Fundamentals
Market Cap 150.64 M
PB Ratio 1.9113
PE Ratio 0.0
Enterprise Value 34.10 M
Total Assets 121.74 M
Volume 57900
Kalaris Therapeutics Inc Company Financials
About Kalaris Therapeutics Inc & investment objective
Company Information Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-stage anti-vascular endothelial growth factor (VEGF) drug for the treatment of neovascular age-related macular degeneration (nAMD), which is in Phase 1b/2, as well as for the treatment of other exudative and neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was founded in 2019 and is headquartered in Berkeley Heights, New Jersey.
Organisation Biotechnology
Employees 14
Industry Biotechnology
CEO Mr. Andrew Oxtoby
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Kalaris Therapeutics Inc FAQs
What is the share price of Kalaris Therapeutics Inc today?
The current share price of Kalaris Therapeutics Inc is $6.56.
Can I buy Kalaris Therapeutics Inc shares in India?
Yes, Indian investors can buy Kalaris Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Kalaris Therapeutics Inc shares in India?
You can easily invest in Kalaris Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Kalaris Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Kalaris Therapeutics Inc.
Can I buy fractional shares of Kalaris Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Kalaris Therapeutics Inc?
Kalaris Therapeutics Inc has a market cap of $150.64 M.
In which sector does Kalaris Therapeutics Inc belong?
Kalaris Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Kalaris Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Kalaris Therapeutics Inc?
The PE ratio of Kalaris Therapeutics Inc is N/A and the PB ratio is 1.91.